Kantar Media Healthcare Research
The Top Drug Classes Advertising in Professional Health Journals Through October 2013
Total print advertising dollars in professional health journals reached more than $491 million through October 2013, a 5% decrease year-over-year, according to Kantar Media. The top product class continues to be Cancer Therapy with nearly $39 million spent advertising in professional health journals year-to-date.... Read More
Top Pharma Companies Advertising in Medical Journals through October 2013
Johnson & Johnson continues to be top spending pharmaceutical company in terms of advertising its products in professional health journals by both pages and dollars, according to Kantar Media. The company also comprises about 7% of the market share year-to-date. Top 5 Print Ad Pharma Companies (Dollars): Jan. – October... Read More
Oral Diabetes Drug Category Shows Large Increase in Professional Health Journal Advertising through October 2013
Advertisers in professional health journals purchased about 79,151 total pages through October 2013, a 6% decrease year-over-year, according to Kantar Media. Cancer Therapy Products continue to be the top drug class advertising by both pages and dollars. While overall pages purchased decreased year-over-year, all five... Read More
Generic vs. Prescription Drugs: Perceptions and Actions
About 16% of adults (37 million) agree that it’s worth paying more for branded prescription medications rather than getting generic products, according to the 2013 OTC/DTC Study. In contrast, 45% of adults (106 million) disagree with that statement. Despite that disparity in attitudes, there are nearly 40 million adults... Read More
Insights into the Evolving Doctor-Patient Relationship
Adults in "excellent" health are more likely to rate their relationship with their doctors positively and vice versa, according to the 2013 MARS OTC/DTC Study. For example, adults in fair or poor health are 52% more likely to describe their relationship as poor and 37% more likely to rate it as fair. Conversely, adults... Read More
Xarelto Spends More Than $12 Million Advertising in Professional Health Journals Through October 2013
Invokana is now the top drug product advertised in professional health journals by pages through October 2013, taking the top spot from oral anticoagulant Xarelto. However, Xarelto continues to be advertised in more pages than Invokana: 1,787 vs. 1,764. Both products fall under Janssen. Many of the products in the top... Read More
More than Three-Fourths of Physicians Use Smartphones for Work Reasons
The number of doctors who use digital devices like smartphones for professional purposes has steadily increased over the last several years. According to current wave data from the Sources & Interactions Study, September 2013: Medical/Surgical Edition, 78% of doctors use smartphones for work reasons, a 6% increase... Read More
More Than Half of Doctors Now Use Tablets for Work Reasons
For the first time since we began tracking physician usage of tablets, more than half of surveyed doctors (51%) say they these devices for professional purposes, according to current wave data from the Sources & Interactions Study, September 2013: Medical/Surgical Edition. This represents a 4% increase from six months... Read More
44% of Adults Received the Flu Vaccine Last Year
About 104 million adults said they received the flu vaccine in the last year – a 9% increase year-over-year, according to the 2013 MARS/OTC DTC Study. Still, less than half of all U.S. adults (44%) say they received the vaccine. Of those that did receive, the majority are over the age of 50. We also found that overall... Read More